Literature DB >> 14748009

Gamma regression improves Haseman-Elston and variance components linkage analysis for sib-pairs.

Mathew J Barber1, Heather J Cordell, Alex J MacGregor, Toby Andrew.   

Abstract

Existing standard methods of linkage analysis for quantitative phenotypes rest on the assumptions of either ordinary least squares (Haseman and Elston [1972] Behav. Genet. 2:3-19; Sham and Purcell [2001] Am. J. Hum. Genet. 68:1527-1532) or phenotypic normality (Almasy and Blangero [1998] Am. J. Hum. Genet. 68:1198-1199; Kruglyak and Lander [1995] Am. J. Hum. Genet. 57:439-454). The limitations of both these methods lie in the specification of the error distribution in the respective regression analyses. In ordinary least squares regression, the residual distribution is misspecified as being independent of the mean level. Using variance components and assuming phenotypic normality, the dependency on the mean level is correctly specified, but the remaining residual coefficient of variation is constrained a priori. Here it is shown that these limitations can be addressed (for a sample of unselected sib-pairs) using a generalized linear model based on the gamma distribution, which can be readily implemented in any standard statistical software package. The generalized linear model approach can emulate variance components when phenotypic multivariate normality is assumed (Almasy and Blangero [1998] Am. J. Hum Genet. 68: 1198-1211) and is therefore more powerful than ordinary least squares, but has the added advantage of being robust to deviations from multivariate normality and provides (often overlooked) model-fit diagnostics for linkage analysis. Copyright 2004 Wiley-Liss, Inc.

Mesh:

Year:  2004        PMID: 14748009     DOI: 10.1002/gepi.10299

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  7 in total

1.  Linkage to the FOXC2 region of chromosome 16 for varicose veins in otherwise healthy, unselected sibling pairs.

Authors:  M Y M Ng; T Andrew; T D Spector; S Jeffery
Journal:  J Med Genet       Date:  2005-03       Impact factor: 6.318

2.  An efficient method to handle the 'large p, small n' problem for genomewide association studies using Haseman-Elston regression.

Authors:  Bujun Mei; Zhihua Wang
Journal:  J Genet       Date:  2016-12       Impact factor: 1.166

3.  Mapping genetic loci that determine leukocyte telomere length in a large sample of unselected female sibling pairs.

Authors:  Toby Andrew; Abraham Aviv; Mario Falchi; Gabriela L Surdulescu; Jeffrey P Gardner; Xiaobin Lu; Masayuki Kimura; Bernet S Kato; Ana M Valdes; Tim D Spector
Journal:  Am J Hum Genet       Date:  2006-01-06       Impact factor: 11.025

4.  Genomewide linkage scan of hand osteoarthritis in female twin pairs showing replication of quantitative trait loci on chromosomes 2 and 19.

Authors:  Gregory Livshits; Bernet S Kato; Guangju Zhai; Deborah J Hart; David Hunter; Alex J MacGregor; Frances M K Williams; Tim D Spector
Journal:  Ann Rheum Dis       Date:  2006-11-24       Impact factor: 19.103

5.  A susceptibility locus for myopia in the normal population is linked to the PAX6 gene region on chromosome 11: a genomewide scan of dizygotic twins.

Authors:  Christopher J Hammond; Toby Andrew; Ying Tat Mak; Tim D Spector
Journal:  Am J Hum Genet       Date:  2004-06-24       Impact factor: 11.025

6.  Quantitative trait loci for bone lengths on chromosome 5 using dual energy X-Ray absorptiometry imaging in the Twins UK cohort.

Authors:  Usha Chinappen-Horsley; Glen M Blake; Ignac Fogelman; Bernet Kato; Kourosh R Ahmadi; Tim D Spector
Journal:  PLoS One       Date:  2008-03-12       Impact factor: 3.240

7.  Identification and replication of three novel myopia common susceptibility gene loci on chromosome 3q26 using linkage and linkage disequilibrium mapping.

Authors:  Toby Andrew; Nikolas Maniatis; Francis Carbonaro; S H Melissa Liew; Winston Lau; Tim D Spector; Christopher J Hammond
Journal:  PLoS Genet       Date:  2008-10-10       Impact factor: 5.917

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.